Investigating whether VISTA+ Tfr cells selectively suppress the cytotoxicity of CD8+ T cells, regulate the differentiation bias of CD4+CD25− T cells, and influence the antibody secretion profile of B cells will provide new perspectives for understanding the complexity of the immune microenvironment in ovarian cancer (26–28). This evidence concerns the gene TFRC and ovarian carcinoma.